Expression of the nucleoside transporters hENT1 (SLC29) and hCNT1 (SLC28) in pediatric acute myeloid leukemia-Reference-Cited by-同舟云学术

Expression of the nucleoside transporters hENT1 (SLC29) and hCNT1 (SLC28) in pediatric acute myeloid leukemia

Published:2020-04-20 Issue:10-12 Volume:39 Page:1379-1388
ISSN:1525-7770
Container-title:Nucleosides, Nucleotides & Nucleic Acids
language:en
Short-container-title:Nucleosides, Nucleotides & Nucleic Acids

Author:

Jaramillo Adrian Christopher¹,Hubeek Isabelle²,Broekhuizen Richard¹³,Pastor-Anglada Marçal⁴,Kaspers Gertjan J. L.⁵⁶,Jansen Gerrit⁷,Cloos Jacqueline¹,Peters Godefridus J.⁸⁹

Affiliation:

1. Depts of Pediatric Hematology, Amsterdam University Medical Centers, Location VUMC, Amsterdam, The Netherlands;

2. Clinical Chemistry, Amsterdam University Medical Centers, Location VUMC, Amsterdam, The Netherlands;

3. Department of Hematology-Oncology, Pontifical Catholic University of Chile, Santiago, Chile;

4. Department de Bioquímica i Biologia Molecular, Universitat de Barcelona, Barcelona, Spain;

5. Princess Maxima Center for Pediatric Cancer, Utrecht, and SKION, The Netherlands;

6. Emma's Children's Hospital, Amsterdam UMC, Location VUMC, Pediatric Oncology, Amsterdam, The Netherlands;

7. Reumatology, Amsterdam University Medical Centers, Location VUMC, Amsterdam, The Netherlands;

8. Laboratory Medical Oncology, Amsterdam University Medical Centers, Location VUMC, Amsterdam, The Netherlands;

9. Department of Biochemistry, Medical University of Gdansk, Gdansk, Poland

Publisher

Informa UK Limited

Subject

Genetics,Molecular Medicine,Biochemistry,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/15257770.2020.1746803

Reference29 articles.

1. The Role of Membrane Transporters in Cellular Resistance to Anticancer Nucleoside Drugs

2. Polymorphisms at microRNA binding sites of Ara-C and anthracyclines-metabolic pathway genes are associated with outcome of acute myeloid leukemia patients

3. The Role of Human Equilibrative Nucleoside Transporter 1 on the Cellular Transport of the DNA Methyltransferase Inhibitors 5-Azacytidine and CP-4200 in Human Leukemia Cells

4. Emerging Roles of Nucleoside Transporters

5. Basis for effective combination cancer chemotherapy with antimetabolites

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of genetic variants in the solute carrier (SLC) genes encoding drug uptake transporters on the response to anticancer chemotherapy;Cancer Drug Resistance;2024-07-18

2. Increased renal elimination of endogenous and synthetic pyrimidine nucleosides in concentrative nucleoside transporter 1 deficient mice;Nature Communications;2023-06-01

3. Nucleoside transporters and immunosuppressive adenosine signaling in the tumor microenvironment: Potential therapeutic opportunities;Pharmacology & Therapeutics;2022-12

4. Systematic Review of Pharmacogenetics of ABC and SLC Transporter Genes in Acute Myeloid Leukemia;Pharmaceutics;2022-04-17

5. Testicular disposition of clofarabine in rats is dependent on equilibrative nucleoside transporters;Pharmacology Research & Perspectives;2021-07-21